Nyxoah SA (NYXH) Noticias

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Nyxoah to Participate in the Piper Sandler 36th Annual Healthcare Conference

Nyxoah to Participate in the Piper Sandler 36th Annual Healthcare Conference Mont-Saint-Guibert, Belgium –...

Invitation to attend the special shareholders’ meeting of the Company to be held on December 19, 2024

REGULATED INFORMATIONNovember 19, 2024, 7:00am CET / 1:00am ET NYXOAH SA(Euronext Brussels/Nasdaq: NYXH) Rue...

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Publication relating to transparency notifications

                 REGULATED INFORMATION Publication relating to transparency notifications Mont-Saint-Guibert...

Form S-8 - Securities to be offered to employees in employee benefit plans

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Nyxoah Reports Third Quarter Financial and Operating Results

REGULATED INFORMATION Nyxoah Reports Third Quarter Financial and Operating ResultsFDA approval on track for...

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Nyxoah Appoints John Landry as Chief Financial Officer

Nyxoah Appoints John Landry as Chief Financial Officer Current CFO, Loïc Moreau, to Transition into Role of...

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Publication relating to transparency notifications

               REGULATED INFORMATION Publication relating to transparency notifications Mont-Saint-Guibert...

Nyxoah to Release Third Quarter 2024 Financial Results on November 6, 2024

Nyxoah to Release Third Quarter 2024 Financial Results on November 6, 2024 Mont-Saint-Guibert, Belgium –...

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Publication relating to transparency notifications

                 REGULATED INFORMATION Publication relating to transparency notifications Mont-Saint-Guibert...